IP Verse

Wilk patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Wilk opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wilk

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3981437	Nucleic Acid Vaccines	MODERNATX	Jul 9, 2025	BIONTECH
EP4023249	Nucleic Acid Vaccines	MODERNATX	Jul 9, 2025	BIONTECH
EP3324979	Infectious Disease Vaccines	MODERNATX	Jul 10, 2023	BIONTECH
EP2791160	Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions	MODERNATX	Dec 2, 2022	BIONTECH
EP3590949	Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof	MODERNATX	Sep 23, 2022	BIONTECH
EP3134131	Nucleic Acid Vaccines	MODERNATX	Sep 22, 2022	BIONTECH
EP3682905	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNATX	Aug 29, 2022	BIONTECH
EP2976418	A Method For Producing A Product (E.G. Polypeptide) In A Continuous Cell Culture Fermentation Process.	CMC BIOLOGICS	Jun 30, 2021	WILK
EP3492109	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNA THERAPEUTICS	Dec 4, 2020	BIONTECH
EP3170842	Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof	CRAGE MEDICAL	Jun 4, 2020	BIONTECH CELL & GENE THERAPIES

Top companies who are the clients of Wilk

Company	Total
BIONTECH	9
BIONTECH CELL & GENE THERAPIES	1
VICTREX MANUFACTURING	1
WILK	1